CAS 1128096-91-2

SR-3306

CAS: 1128096-91-2

SR-3306

Purity: ≥98%

Molecular weight: 490.56g/mol

Ref: 54-BUP12804

Sr-3306

CAS: 1128096-91-2

Sr-3306

Molecular weight: 490.55903g/mol

Ref: 54-BISN0314

Sr-3306

CAS: 1128096-91-2

Sr-3306 is a nonsteroidal anti-inflammatory drug (NSAID) that is the active form of the prodrug sulfasalazine. It inhibits prostaglandin synthesis by blocking cyclooxygenase (COX) activity and preventing the conversion of arachidonic acid to prostaglandins, which are important mediators of inflammation. Sr-3306 also inhibits COX-2 expression through a variety of mechanisms, including inhibition of NF-κB signaling pathways and activation of peroxisome proliferator-activated receptor gamma (PPARγ). It has been shown to inhibit cell growth in cancer cells and has neuroprotective effects against dopamine toxicity in animal models. In addition, it has been shown to inhibit epidermal growth factor (EGF), which causes inflammation and tumorigenesis, as well as inhibitory effects on the development of acute ischemic stroke.

Formula: C₂₈H₂₆N₈O

Purity: Min. 95%

Molecular weight: 490.56 g/mol

Ref: 3D-DVB09691

SR-3306

CAS: 1128096-91-2

SR-3306 is a brain-penetrant and selective pan-JNK (JNK1/2/3) inhibitor with IC50 values ​​of 67 nM, 283 nM, 159 nM.Cost-effective and quality-assured.

Formula: C₂₈H₂₆N₈O

Purity: 99.38% - 99.71%

Color and Shape: Solid

Molecular weight: 490.56

Ref: TM-T16927